STATBiogen's Alzheimer's drug slows cognitive decline in early studyOct 25, 2023Adam FeuersteinBy Adam Feuersteinmore_vert
Biogen | Investor RelationsEisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and ...Oct 25, 2023more_vert
CNBCMore convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in studyOct 25, 2023Annika Kim ConstantinoBy Annika Kim Constantinomore_vert